Litigation between judges on the Federal Circuit bench not only raises significant issues, it threatens to leave “wounds” that will “take a long time to heal, if they ever do,” says Prof. Paul Gugliuzza. Read More

A dispute over Judge Pauline Newman’s fitness on the Federal Circuit bench has spilled into litigation. Prof. Paul Gugliuzza lays out the issues for Patently-O. Read More

The music industry is wrestling with the ethics of AI-generated work using the voices of dead artists. Prof. Funmi Arewa notes that the digital era has compounded longstanding exploitation of Black artists in particular. Read More

As officials on the Southern border prepare for an influx of asylum-seekers, Assoc. Dean Jaya Ramji-Nogales notes that one reason for the situation there is the removal of safe pathways elsewhere, leaving them no other choice. Read More

As details emerge about alleged lottery manipulation by a Philadelphia charter school, Prof. Susan DeJarnatt calls for the law governing such institutions to be strengthened. Read More

Prof. Scott Burris, who leads Temple’s Center for Public Health Law Research, talks about how legal epidemiology can help us understand the impact of law on public health. Read More

Even the current members of the Supreme Court might find a federal court’s attempt to undercut FDA’s congressionally approved authority “too much,” says Dean Rachel Rebouche. Read More

A Texas judge might soon order the FDA to withdraw mifepristone from the market. Dean Rebouche says such an order would sow confusion and may violate federal law. Read More

Dean Rachel Rebouche joins KALW’s Your Call to discuss a court decision that could reverse FDA approval of mifepristone, one of two drugs used in self-managed abortions. Read More

Uproar over Walgreens’ decision not to dispense abortion pills in some states where they are legal is reflective of the chaos unleashed by Dobbs, says Dean Rebouche. She says other companies are watching to see what happens next in the “court of public opinion.” Read More